Results exceeded market expectations and included an 18 percent jump in revenue for its hospital business.
9:58 am today
Chief executive Lewis Gradon said its hospital business performed strongly, with revenue in the division up 18 percent from a year ago.
New Zealand's most valuable NZX-listed company, Fisher & Paykel Healthcare, has reported a 24 percent increase in profit driven by strong sales in hospital products and improving margins.
Key numbers for the 12 months ended March compared with a year ago:
Net profit $468.5m vs $377.2m
Fisher & Paykel Healthcare profit jumps 24% to $468.5m as hospital demand surges
'Very cheap': Why analysts believe F&P Healthcare is tipped for a rebound
Infratil boosts earnings as CDC dominates valuation, One NZ dominates profit contribution
Market close: Contact block trade buoys NZX as Infratil hits record, NZ exports surge
Netcare first-half profit rises as demand remains resilient
WATCH | Netcare’s first-half profit rises on resilient demand
Altron declares special dividend as profit surges
Altron's share price surges 15 percent after special dividend, successful strategic overhaul
AI spending boom sees Nvidia post record $136b quarterly revenue
Honasa Consumer shares zoom 11% on robust Q4. Jefferies, CLSA see more room to run
Net profit hit $468.5m as the hospital division delivered strong growth.
The company still trades on a price/earnings multiple of 43 times.
Craigs now rates F&P Healthcare 'overweight', calling the stock oversold.
Revenue rose to $100.3m from $94.5m, reflecting higher sales volumes and improved pricing across key markets.
Firm forecasts stronger FY27 but there are limits to the AI magic as One NZ's value falls.
The company won't pay a full year dividend as a result of negative cashflow, with net profit for the 12 months ended March of…
